Transcending Blood—Opportunities for Alternate Liquid Biopsies in Oncology

Transcending Blood—Opportunities for Alternate Liquid Biopsies in Oncology

Cell-free DNA (cfDNA) is a useful molecular biomarker in oncology research and treatment, but while research into its properties in blood has flourished, there remains much to be discovered about cfDNA in other body fluids. The cfDNA from saliva, sputum, cerebrospinal fluid, urine, faeces, pleural e...

Full description

Bibliographic Details
Main Authors:	Bonnita Werner, Kristina Warton, Caroline E. Ford
Format:	Article
Language:	English
Published:	MDPI AG 2022-03-01
Series:	Cancers
Subjects:	cell-free DNA (cfDNA) ctDNA solid tumours liquid biopsy precision medicine biomarkers
Online Access:	https://www.mdpi.com/2072-6694/14/5/1309

Similar Items

Using cfDNA and ctDNA as Oncologic Markers: A Path to Clinical Validation
by: Jonathan Dao, et al.
Published: (2023-08-01)

Liquid biopsy: current technology and clinical applications
by: Mina Nikanjam, et al.
Published: (2022-09-01)

Can Liquid Biopsy Based on ctDNA/cfDNA Replace Tissue Biopsy for the Precision Treatment of EGFR-Mutated NSCLC?
by: Yi-Ze Li, et al.
Published: (2023-02-01)

Liquid biopsy: New opportunities for precision medicine in hepatocellular carcinoma care
by: Inah Marie C. Aquino, et al.
Published: (2024-03-01)

Mutated circulating tumor DNA as a liquid biopsy in lung cancer detection and treatment
by: Martyna Filipska, et al.
Published: (2021-06-01)

Evaluation of commercial kits for isolation and bisulfite conversion of circulating cell-free tumor DNA from blood
by: Stine H. Kresse, et al.
Published: (2023-09-01)

The evidence base for circulating tumour DNA blood-based biomarkers for the early detection of cancer: a systematic mapping review
by: Ian A. Cree, et al.
Published: (2017-10-01)

Extracellular Vesicle-Derived DNA vs. CfDNA as a Biomarker for the Detection of Colon Cancer
by: Kavita Thakur, et al.
Published: (2021-07-01)

Liquid biopsy in T-cell lymphoma: biomarker detection techniques and clinical application
by: Zongyao Huang, et al.
Published: (2024-02-01)

Liquid Biopsy &ndash; Possibilities for Monitoring&nbsp;the Therapeutic Response in Non-Small Cell Lung Cancer
by: Gabriela A. Raycheva, et al.
Published: (2021-12-01)

Sensitive and Specific Analyses of Colorectal Cancer Recurrence through Multiplex superRCA Mutation Detection in Blood Plasma
by: Emma Sandberg, et al.
Published: (2024-01-01)

Liquid Biopsy in Diagnosis and Prognosis of Non-Metastatic Prostate Cancer
by: Alexey S. Rzhevskiy, et al.
Published: (2022-12-01)

Rational Development of Liquid Biopsy Analysis in Renal Cell Carcinoma
by: Kate I. Glennon, et al.
Published: (2021-11-01)

New Perspectives on the Importance of Cell-Free DNA Biology
by: Abel J. Bronkhorst, et al.
Published: (2022-09-01)

Combining Solid and Liquid Biopsy for Therapy Monitoring in Esophageal Cancer
by: Florian Richter, et al.
Published: (2023-06-01)

Beyond the Blood: CSF-Derived cfDNA for Diagnosis and Characterization of CNS Tumors
by: Abbye E. McEwen, et al.
Published: (2020-02-01)

Promises and Challenges of Predictive Blood Biomarkers for Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy
by: Joao Victor Machado Carvalho, et al.
Published: (2023-01-01)

ACT-Discover: identifying karyotype heterogeneity in pancreatic cancer evolution using ctDNA
by: Ariana Huebner, et al.
Published: (2023-04-01)

BL-MOL-AR Project, Preliminary Results about Liquid Biopsy: Molecular Approach Experience and Research Activity in Oncological Settings
by: Pancrazzi Pancrazzi, et al.
Published: (2023-09-01)

Clinical Validity of Circulating Tumor DNA as Prognostic and Predictive Marker for Personalized Colorectal Cancer Patient Management
by: Ariane Hallermayr, et al.
Published: (2022-02-01)

International pilot external quality assessment scheme for analysis and reporting of circulating tumour DNA
by: Cleo Keppens, et al.
Published: (2018-08-01)

Pre-Analytical Evaluation of Streck Cell-Free DNA Blood Collection Tubes for Liquid Profiling in Oncology
by: Inga Medina Diaz, et al.
Published: (2023-03-01)

Comprehensive Genomic Profiling of Circulating Cell-Free DNA Distinguishes Focal <i>MET</i> Amplification from Aneuploidy in Diverse Advanced Cancers
by: Yuichi Kumaki, et al.
Published: (2021-09-01)

Technical Evaluation of Commercial Mutation Analysis Platforms and Reference Materials for Liquid Biopsy Profiling
by: Sabrina Weber, et al.
Published: (2020-06-01)

The Emerging Role of Liquid Biopsy in Gastric Cancer
by: Csongor György Lengyel, et al.
Published: (2021-05-01)

Circulating Tumor DNA in Head and Neck Squamous Cell Carcinoma: Association with Metabolic Tumor Burden Determined with FDG-PET/CT
by: Antti Silvoniemi, et al.
Published: (2023-08-01)

Translational Utility of Liquid Biopsies in Thyroid Cancer Management
by: Ayanthi A. Wijewardene, et al.
Published: (2021-07-01)

Liquid Biopsies for Colorectal Cancer and Advanced Adenoma Screening and Surveillance: What to Measure?
by: Ellis L. Eikenboom, et al.
Published: (2023-09-01)

Retrospective Evaluation of Somatic Alterations in Cell-Free DNA from Blood in Retinoblastoma
by: David H. Abramson, MD, et al.
Published: (2021-03-01)

Impact of cfDNA Reference Materials on Clinical Performance of Liquid Biopsy NGS Assays
by: Ariane Hallermayr, et al.
Published: (2023-10-01)

Tekočinska biopsija pri raku
by: Tanja Jesenko, et al.
Published: (2018-09-01)

Individualized Mini-Panel Sequencing of ctDNA Allows Tumor Monitoring in Complex Karyotype Sarcomas
by: David Braig, et al.
Published: (2022-09-01)

The Role of Cell-Free DNA in Cancer Treatment Decision Making
by: András Telekes, et al.
Published: (2022-12-01)

The potential for liquid biopsies in the precision medical treatment of breast cancer
by: Victoria A. Forte, et al.
Published: (2016-03-01)

Liquid Biopsy for Biomarker Testing in Non-Small Cell Lung Cancer: A European Perspective
by: Umberto Malapelle, et al.
Published: (2021-08-01)

Cross-platform comparisons for targeted bisulfite sequencing of MGISEQ-2000 and NovaSeq6000
by: Jin Sun, et al.
Published: (2023-08-01)

Potential Impact of Preoperative Circulating Biomarkers on Individual Escalating/de-Escalating Strategies in Early Breast Cancer
by: Caterina Gianni, et al.
Published: (2022-12-01)

Circulating Tumour DNA as Biomarker for Colorectal Liver Metastases: A Systematic Review and Meta-Analysis
by: Lissa Wullaert, et al.
Published: (2023-10-01)

Liquid Biopsy in Glioblastoma: Opportunities, Applications and Challenges
by: Ander Saenz-Antoñanzas, et al.
Published: (2019-07-01)

Nanopore sequencing from liquid biopsy: analysis of copy number variations from cell-free DNA of lung cancer patients
by: Filippo Martignano, et al.
Published: (2021-02-01)